Cargando…
Liquid Biopsy for Lung Cancer: Up-to-Date and Perspectives for Screening Programs
Lung cancer is the deadliest cancer worldwide. Tissue biopsy is currently employed for the diagnosis and molecular stratification of lung cancer. Liquid biopsy is a minimally invasive approach to determine biomarkers from body fluids, such as blood, urine, sputum, and saliva. Tumor cells release cfD...
Autores principales: | Casagrande, Giovanna Maria Stanfoca, Silva, Marcela de Oliveira, Reis, Rui Manuel, Leal, Letícia Ferro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9917347/ https://www.ncbi.nlm.nih.gov/pubmed/36768828 http://dx.doi.org/10.3390/ijms24032505 |
Ejemplares similares
-
Breast cancer: an up‐to‐date review and future perspectives
por: Hong, Ruoxi, et al.
Publicado: (2022) -
Are Older Adults Up-to-Date With Cancer Screening and Vaccinations?
por: Shenson, Douglas, et al.
Publicado: (2005) -
Editorial: HBOC and high-risk screening: up-to-date
por: Kataoka, Masako
Publicado: (2021) -
MicroRNA Biomarkers of High-Grade Cervical Intraepithelial Neoplasia in Liquid Biopsy
por: Causin, Rhafaela L., et al.
Publicado: (2021) -
DNA methylation fingerprint of hepatocellular carcinoma from tissue and liquid biopsies
por: Gonçalves, Emanuel, et al.
Publicado: (2022)